Yahoo Poland Wyszukiwanie w Internecie

Search results

1. psychiatryonline.org › doi › 10Lumateperone: A Truly Innovative Antipsychotic Medication?

   psychiatryonline.org › doi › 10

   1 mar 2023 · Lumateperone (Caplyta, Intra-Cellular Therapies) is a new antipsychotic medication, approved by the Food and Drug Administration (FDA) in 2019 for adults with schizophrenia and approved in 2021 for adults with depressive episodes associated with bipolar I or II disorder.

2. psychiatryonline.org › doi › 10Caplyta Now Approved for Bipolar Depression | Psychiatric News

   psychiatryonline.org › doi › 10

   With the FDA’s expanded indication, Caplyta (lumateperone) becomes just the second medication for both bipolar I and bipolar II depression. It is also the first approved for use in combination with lithium or valproate for bipolar II depression.

3. www.psychiatrictimes.com › view › fda-approves-new-treatment-for-bipolar-depressionFDA Approves New Treatment for Bipolar Depression - Psychiatric...

   www.psychiatrictimes.com › view › fda-approves-new-treatment-for-bipolar-depression

   • Zapisane w pamięci cache

   21 gru 2021 · Caplyta, an atypical antipsychotic from biopharmaceutical company Intra-Cellular Therapies, is the only drug approved by the FDA for the treatment of depressive episodes stemming from bipolar I or bipolar II disorder in adults as monotherapy or adjunctive therapy with either valproate or lithium.

4. www.medpagetoday.com › psychiatry › bipolardisorderFDA Greenlights New Drug for Bipolar Depression - Medpage Today

   www.medpagetoday.com › psychiatry › bipolardisorder

   • Zapisane w pamięci cache

   20 gru 2021 · The FDA approved lumateperone (Caplyta) for bipolar-related depressive episodes, Intra-Cellular Therapies announced Monday. The atypical antipsychotic gained an indication for the...

5. jaapl.org › content › 43/4/456A Proposed Algorithm for the Pharmacotherapy of Impulsive...

   jaapl.org › content › 43/4/456

   • Zapisane w pamięci cache

   1 gru 2015 · Treatment of the principal disorder can reduce aggressive behavior that is secondary to the condition. Sometimes the very medicine used to treat the principal disorder happens to be an effective AIAA: a mood stabilizer for bipolar disorder, for example.

6. www.drugs.com › condition › bipolar-disorderList of 61 Bipolar Disorder Medications Compared - Drugs.com

   www.drugs.com › condition › bipolar-disorder

   • Zapisane w pamięci cache

   19 lut 2024 · Bipolar disorder is best treated with a combination of medications (such as mood-stabilizing agents, antipsychotics, antidepressants, or benzodiazepines), therapy sessions, and good personal routines.

7. www.healthline.com › health › bipolar-disorderBipolar Disorder and Anger: Why It Happens and How to Cope -...

   www.healthline.com › health › bipolar-disorder

   • Zapisane w pamięci cache

   25 kwi 2024 · Prescription medication is one of the primary treatments for bipolar disorder. Some people take mood stabilizers such as lithium (Lithobid). While anger isn’t a side effect of mood stabilizers,...